Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy

Abstract

DEPDC5 is an upstream repressor of the mechanistic target of rapamycin pathway via the GATOR-1 complex. Pathogenic variants causing loss of function typically result in familial focal epilepsy with variable foci. Neuroimaging may either be normal or show brain malformations. Lesional and nonlesional cases may be present within the same family. Here, we describe a parent–child dyad affected by a truncating DEPDC5 pathogenic variant (c.727C > T; p.Arg243*), analyze the epilepsy clinical course, and describe neuroimaging characteristics from a 3T brain magnetic resonance imaging. Despite sharing the same variant, patients diverged both in terms of epilepsy severity and neuroimaging features. Surprisingly, the mother is still suffering from drug-resistant seizures and has normal neuroimaging, while the child has been experiencing prolonged seizure freedom notwithstanding a bottom-of-sulcus focal cortical dysplasia. An increasing gradient of severity has been proposed for families with GATOR1-related epilepsies. We confirm clinical and neuroradiological expressivities are variable and also suggest the prognostication of epilepsy outcome may be particularly difficult. The epilepsy outcome could partially be independent from brain structural abnormalities.

Keywords

mTOR - brain MRI - seizures - focal cortical dysplasia - germinal variants - pathogenic variants

^* These authors contributed equally to this work.

Publication History

Received: 16 August 2022

Accepted: 29 March 2023

Accepted Manuscript online:
01 April 2023

Article published online:
27 April 2023

• References

• 1 Scheffer IE, Heron SE, Regan BM. et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014; 75 (05) 782-787
• 2 Marsan E, Baulac S. Review: mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 2018; 44 (01) 6-17
• 3 Mühlebner A, Bongaarts A, Sarnat HB, Scholl T, Aronica E. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives. J Anat 2019; 235 (03) 521-542
• 4 Mirzaa GM, Campbell CD, Solovieff N. et al. Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol 2016; 73 (07) 836-845
• 5 Ricos MG, Hodgson BL, Pippucci T. et al; Epilepsy Electroclinical Study Group. Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol 2016; 79 (01) 120-131
• 6 Samanta D. DEPDC5-related epilepsy: a comprehensive review. Epilepsy Behav 2022; 130: 108678
• 7 Baldassari S, Ribierre T, Marsan E. et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol 2019; 138 (06) 885-900
• 8 Baulac S, Ishida S, Marsan E. et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 2015; 77 (04) 675-683
• 9 Benova B, Sanders MWCB, Uhrova-Meszarosova A. et al. GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: a possible gradient in severity?. Eur J Paediatr Neurol 2021; 30: 88-96
• 10 Dibbens LM, de Vries B, Donatello S. et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013; 45 (05) 546-551
• 11 Lee WS, Stephenson SEM, Howell KB. et al. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA. Ann Clin Transl Neurol 2019; 6 (07) 1338-1344
• 12 Lal D, Reinthaler EM, Schubert J. et al. DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol 2014; 75 (05) 788-792
• 13 Baldassari S, Picard F, Verbeek NE. et al. The landscape of epilepsy-related GATOR1 variants. Genet Med 2019; 21 (02) 398-408